Literature DB >> 2445461

Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiency.

B F McLeod1, H J Lawrence, D W Smith, P J Vogt, D R Gandara.   

Abstract

A 54-year-old man with advanced non-Hodgkin's lymphoma and chronic renal insufficiency was treated with combination chemotherapy which included bleomycin. Fatal pulmonary toxicity developed after administration of a total bleomycin dose of only 60 U. Transbronchial biopsy and autopsy demonstrated pathologic findings consistent with bleomycin-induced pulmonary fibrosis. High-dose corticosteroid therapy did not appear to alter the clinical course. Extreme caution should be exercised when administering bleomycin to patients with renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445461     DOI: 10.1002/1097-0142(19871201)60:11<2617::aid-cncr2820601107>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Acute fibrinous and organising pneumonia: a rare histopathological variant of chemotherapy-induced lung injury.

Authors:  Arjun Gupta; Shiraj Sen; Harris Naina
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Bleomycin lung: a case report.

Authors:  Rabia Sofia Rashid
Journal:  BMJ Case Rep       Date:  2009-04-14

3.  Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin.

Authors:  Benjamin M Aakre; Richard I Efem; Gregory A Wilson; Daryl J Kor; John H Eisenach
Journal:  Mayo Clin Proc       Date:  2014-02       Impact factor: 7.616

Review 4.  Cancer chemotherapy in older adults. A tolerability perspective.

Authors:  G G Kimmick; R Fleming; H B Muss; L Balducci
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

5.  Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours.

Authors:  A B Simpson; J Paul; J Graham; S B Kaye
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

6.  Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice.

Authors:  Adilson Santos Andrade-Sousa; Paulo Rogério Pereira; BreAnne MacKenzie; Manoel Carneiro Oliveira-Junior; Erasmo Assumpção-Neto; Maysa Alves Rodrigues Brandão-Rangel; Nilsa Regina Damaceno-Rodrigues; Elia Garcia Caldini; Ana Paula Pereira Velosa; Walcy Rosolia Teodoro; Ana Paula Ligeiro de Oliveira; Marisa Dolhnikoff; Oliver Eickelberg; Rodolfo Paula Vieira
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

Review 7.  Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK.

Authors:  Robert A Watson; Hugo De La Peña; Maria T Tsakok; Johnson Joseph; Sara Stoneham; Jonathan Shamash; Johnathan Joffe; Danish Mazhar; Zoe Traill; Ling-Pei Ho; Sue Brand; Andrew S Protheroe
Journal:  Br J Cancer       Date:  2018-10-25       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.